Es. Lightcap et Rb. Silverman, SLOW-BINDING INHIBITION OF GAMMA-AMINOBUTYRIC-ACID AMINOTRANSFERASE BY HYDRAZINE ANALOGS, Journal of medicinal chemistry, 39(3), 1996, pp. 686-694
(3-Hydroxybenzyl)hydrazine and methylhydrazine have been found to be p
otent slow-binding inhibitors of the pyridoxal 5-phosphate (PLP)-depen
dent enzyme gamma-aminobutyric acid aminotransferase (GABA-AT). Both c
ompounds follow mechanism A (Morrison, J. F.; Walsh, C. T. Adv. Enzymo
l. 1988, 61, 201-301) which does not involve formation of a rapidly re
versible enzyme-inhibitor complex before the formation of the final ti
ght complex. The rate constant for formation of the enzyme-inhibitor c
omplex determined from the slow-binding kinetics was 2.08 x 10(3) and
1.98 x 10(4) M(-1) min(-1) for methylhydrazine and (3-hydroxybenzyl)hy
drazine, respectively. The rate constant for dissociation of the enzym
e-inhibitor complex determined for the slow-binding kinetics was 4.6 x
10(-3) and 5 x 10(-3) min(-1), respectively. The inhibition constants
calculated from the slow-binding inhibition kinetics are 2.2 mu M for
methylhydrazine and 0.3 mu M for (3-hydroxybenzyl)hydrazine. Reactiva
tion of the inhibited enzyme was not first order, perhaps due to a sid
e reaction of the hydrazine, but was consistent with the results obtai
ned from the slow-binding kinetics. Inhibition constants were calculat
ed from the level of enzyme activity at equilibrium inhibition. These
constants are 2.8 and 0.46 mu M for methylhydrazine and (3-hydroxybenz
yl)hydrazine, respectively, in good agreement with those calculated fr
om the slow-binding inhibition kinetics. 3-Hydrazinopropionate also be
haved as a slow-binding inhibitor. However, the dependence of its kine
tics on the concentration of inhibitor could not be described by the s
low-binding or slow, tight-binding inhibition models. These kinetics c
ould not be described by the tight-binding character of the inhibition
because the addition of the competitive inhibitor propionic acid at 1
00 times its K-i did not affect the shape of the curve for inhibitor c
oncentration dependence. The slow-binding inhibition appeared to requi
re 2-4 molecules of 3-hydrazinopropionate/enzyme. The reactivation of
enzyme inhibited by 3-hydrazinopropionate was first order with a rate
constant of 6.9 x 10(-3) min(-1). Its equilibrium inhibition constant
was calculated to be <20 nM. However, the inhibition constant calculat
ed was dependent on the concentration of inhibitor because of the unus
ual character discussed above and may be much lower. Only 1 PLP/enzyme
dimer reacted with methylhydrazine or (3-hydroxybenzyl)hydrazine, as
indicated by Scatchard plots, or with 3-hydrazinopropionate, as shown
by a spectrophotometric titration. Slow-binding inhibition does not ap
pear to be the result of a significant enzyme conformational change be
cause there is no change in the tryptophan fluorescence of GABA-AT upo
n binding either methylhydrazine or 3-hydrazinopropionate. Implication
s for the design of hydrazine inhibitors of GABA-AT are discussed.